PHARMACYTE BIOTECH, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PHARMACYTE BIOTECH, INC. (PMCB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 12-month period ending 2017-04-30, per its 10-K filed 2017-07-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-07-27
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $0.00.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$3.56M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 10-K · filed 2017-07-27 | ||
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 10-Q · filed 2017-03-13 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 | ||
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | $0.00 10-Q · filed 2016-12-02 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 | ||
| 2016-07-31 | $0.00 10-Q · filed 2016-09-06 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 | ||
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 10-K · filed 2017-07-27 | ||
| 2016-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 10-Q · filed 2017-03-13 | $500.00K derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | $0.00 10-Q · filed 2016-12-02 | $500.00K derived: sum of 3 quarters · filed 2016-12-02 | $0.00 derived: sum of 4 quarters · filed 2016-12-02 | ||
| 2015-07-31 | $0.00 10-Q · filed 2016-09-06 | $500.00K derived: sum of 2 quarters · filed 2016-09-06 | $0.00 derived: sum of 3 quarters · filed 2016-09-06 | $0.00 derived: sum of 4 quarters · filed 2016-09-06 | ||
| 2015-04-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 | ||
| 2015-01-31 | -$500.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2015-03-13 | -$500.00K derived: sum of 2 quarters · filed 2016-01-19 | -$500.00K 10-Q · filed 2015-03-13 | -$1.51M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-10-31 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $0.00 10-Q/A · filed 2016-01-19 | -$250.00K 10-Q · filed 2014-12-15 | -$1.01M derived: sum of 3 quarters · filed 2016-07-29 | -$1.01M derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-07-31 | $0.00 10-Q/A · filed 2016-01-19 | -$1.01M derived: sum of 2 quarters · filed 2016-07-29 | -$1.01M derived: sum of 3 quarters · filed 2016-07-29 | -$1.99M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-04-30 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$1.01M derived: sum of 2 quarters · filed 2016-07-29 | -$1.99M derived: sum of 3 quarters · filed 2016-07-29 | -$3.56M 10-K · filed 2016-07-29 | -$3.55M 10-K · filed 2014-08-04 | |
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | -$982.37K derived: sum of 2 quarters · filed 2015-03-13 | -$2.55M 10-Q · filed 2015-03-13 | -$2.72M derived: sum of 4 quarters · filed 2016-01-19 | ||
| 2013-10-31 | -$982.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$2.55M 10-Q · filed 2014-12-15 | -$2.72M derived: sum of 3 quarters · filed 2016-01-19 | |||
| 2013-07-31 | -$1.57M 10-Q · filed 2014-09-15 | -$1.73M derived: sum of 2 quarters · filed 2016-01-19 | ||||
| 2013-04-30 | -$165.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | -$646.75K 10-K/A · filed 2016-01-19 | ||||
| 2013-01-31 | -$481.75K 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |